Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 8, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for June 11, 2007 Subscribe to this News Feed      
 

LegalView.com Launches Avandia Information Portal with Information on the Latest FDA Warnings

LegalView.com, your resource for everything legal, has launched a new online resource for information on the diabetes drug Avandia located at http://avandia.legalview.com, with details on FDA warnings and recent medical studies.

(PRWEB) June 11, 2007 -- LegalView, your resource on the Web for everything legal, is proud to introduce its new web site on Avandia (rosiglitazone maleate), in response to recent concerns about the drug's safety, at http://avandia.legalview.com. This new legal resource is intended to be a free, comprehensive collection of information for anyone concerned about the drastically increased risk of heart attacks and other serious cardiac events that has been linked to Avandia, a drug prescribed to control Type 2 diabetes. The site joins LegalView's existing collection of information on more than 40 other unsafe drugs, defective medical devices and other hot-button legal topics.

Although FDA warnings released over the last several years had already linked Avandia with a number of serious side effects, patient concerns were drastically heightened May 21st, when The New England Journal of Medicine announced a study showing Avandia increases patients' risk of heart attack by 43 percent. This is especially alarming because these patients are already at serious risk for heart problems -- two-thirds of diabetics die of heart or blood vessel diseases, according to the American Heart Association. These new side effects join existing, known side effects including liver damage, edema and heart problems due to fluid buildup. As a result of this latest study, the FDA has issued a warning suggesting that Avandia patients talk to their doctors to determine whether the drug is still their best option. Congress has also held hearings on how the drug came to be approved.

Patients, their loved ones and any other visitors concerned about these findings can browse LegalView's collection of original articles on Avandia, news, FDA announcements and encyclopedia articles. As results of ongoing studies and news articles on Avandia continue to arrive, LegalView.com's Avandia information portal will be updated to provide the public with timely information on this important topic.

The new Avandia Web portal joins LegalView's large collection of information on more than 30 medications thought or known to be unsafe, as well as comprehensive portals on other legal topics important to Americans -- birth injuries, car and truck accidents, unsafe consumer products and many more. Visitors are invited to browse an extensive collection of informational articles, news feeds, legal blogs and local legal resources. And those looking for an experienced attorney in their areas can always take advantage of LegalView's fast, free online lawyer referral service.

LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a national group of distinguished law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.com.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U2luZy1QaWdnLUZhbHUtU2luZy1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Peter Kent
LegalView.com
720-771-3246
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright